BR112012025082A2 - novos anticorpos monoclonais e método de análise imunológica de dímero-d - Google Patents

novos anticorpos monoclonais e método de análise imunológica de dímero-d

Info

Publication number
BR112012025082A2
BR112012025082A2 BR112012025082A BR112012025082A BR112012025082A2 BR 112012025082 A2 BR112012025082 A2 BR 112012025082A2 BR 112012025082 A BR112012025082 A BR 112012025082A BR 112012025082 A BR112012025082 A BR 112012025082A BR 112012025082 A2 BR112012025082 A2 BR 112012025082A2
Authority
BR
Brazil
Prior art keywords
dimer
monoclonal antibodies
immunoassay method
new monoclonal
new
Prior art date
Application number
BR112012025082A
Other languages
English (en)
Other versions
BR112012025082A8 (pt
Inventor
George Sakurai
Junko Nozaki
Yutaka Nagahama
Original Assignee
Mitsubishi Chem Medience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Medience Corp filed Critical Mitsubishi Chem Medience Corp
Publication of BR112012025082A2 publication Critical patent/BR112012025082A2/pt
Publication of BR112012025082A8 publication Critical patent/BR112012025082A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112012025082A 2010-04-01 2011-03-31 Novos anticorpos monoclonais e método de análise imunológica de dímero-d BR112012025082A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010084863 2010-04-01
PCT/JP2011/058286 WO2011125875A1 (ja) 2010-04-01 2011-03-31 新規モノクローナル抗体ならびにｄダイマーの免疫学的測定法

Publications (2)

Publication Number Publication Date
BR112012025082A2 true BR112012025082A2 (pt) 2015-09-22
BR112012025082A8 BR112012025082A8 (pt) 2017-10-10

Family

ID=44762813

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012025082A BR112012025082A8 (pt) 2010-04-01 2011-03-31 Novos anticorpos monoclonais e método de análise imunológica de dímero-d

Country Status (9)

Country Link
US (1) US9206250B2 (pt)
EP (1) EP2554673B1 (pt)
JP (1) JP5860394B2 (pt)
KR (1) KR101877457B1 (pt)
CN (2) CN107602698A (pt)
BR (1) BR112012025082A8 (pt)
ES (1) ES2655099T3 (pt)
HK (1) HK1248249A1 (pt)
WO (1) WO2011125875A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5903381B2 (ja) * 2010-07-30 2016-04-13 シスメックス株式会社 抗ｆｄｐモノクローナル抗体、それを用いたｆｄｐ測定用試薬及び試薬キット、並びにｆｄｐ測定方法
CN103026231B (zh) * 2010-07-30 2015-06-24 希森美康株式会社 Fdp测定用试剂及试剂盒、以及测定方法
CN103033629B (zh) * 2012-12-12 2015-02-25 元升生物科技（上海）有限公司 一种脂蛋白磷脂酶a2的测定试剂及试剂的制备方法
CN103468644B (zh) * 2013-09-26 2016-01-20 重庆探生科技有限公司 产生抗人d-二聚体的单克隆抗体的杂交瘤细胞株及制备方法和应用
JP6770571B2 (ja) * 2016-02-22 2020-10-14 株式会社Ｌｓｉメディエンス 架橋化フィブリン分解産物の測定試薬および測定方法
JP6667380B2 (ja) 2016-06-17 2020-03-18 シスメックス株式会社 血液分析のための方法、血液分析装置、コンピュータプログラム、キャリブレータセット、及びキャリブレータセットの作製方法
CN110028582B (zh) * 2019-04-29 2022-03-25 江苏众红生物工程创药研究院有限公司 抗人d-二聚体抗体及其应用
MX2022008213A (es) * 2020-02-20 2022-08-04 Hoffmann La Roche Anticuerpos anti dimero d recombinantes, procedimientos y utilizaciones de los mismos.
CN117866100A (zh) * 2024-03-11 2024-04-12 北京市心肺血管疾病研究所 针对d-二聚体的单域抗体或其抗原结合片段及其相关生物材料与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572125B2 (en) * 1983-03-17 1988-05-05 Mabco Limited Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
JPS6379900A (ja) * 1986-09-22 1988-04-09 Yatoron:Kk モノクロ−ナル抗体と検出方法
JP3889084B2 (ja) * 1996-05-15 2007-03-07 株式会社三菱化学ヤトロン 新規なモノクローナル抗体並びにｅ−Ｄダイマー及びｅ−ＤＤ／Ｅ複合体の免疫学的測定法
JP3857468B2 (ja) 1999-07-12 2006-12-13 株式会社三菱化学ヤトロン Ｄダイマー及びｄｄ／ｅ複合体の免疫学的分析方法及び分析用キット
WO2003039234A2 (en) * 2001-11-06 2003-05-15 David Pickar Pharmacogenomics-based system for clinical applications
JP4448754B2 (ja) 2004-09-30 2010-04-14 シスメックス株式会社 Ｄダイマー測定用試薬およびこれに用いるモノクローナル抗体
JP4589756B2 (ja) * 2005-02-25 2010-12-01 シスメックス株式会社 Ｄダイマー測定用キット
CN101166977B (zh) * 2005-04-28 2012-09-05 三菱化学美迪恩斯株式会社 稳定化纤维蛋白的纤维蛋白溶酶分解物的免疫学分析方法
WO2007013709A1 (en) * 2005-07-29 2007-02-01 Biobud Co., Ltd. Monoclonal antibody against d-dimer and diagnosis agent for detecting d-dimer, crosslinked fibrin and its derivatives containing d-dimer by using the antibody
ES2621923T3 (es) * 2007-09-11 2017-07-05 The Board Of Trustees Of The Leland Stanford Junior University Biomarcador para medir la eficacia de un fármaco en enfermedad enteropática

Also Published As

Publication number Publication date
EP2554673B1 (en) 2017-10-25
EP2554673A1 (en) 2013-02-06
WO2011125875A1 (ja) 2011-10-13
KR101877457B1 (ko) 2018-07-11
US9206250B2 (en) 2015-12-08
JPWO2011125875A1 (ja) 2013-07-11
CN107602698A (zh) 2018-01-19
EP2554673A4 (en) 2014-05-21
KR20130032869A (ko) 2013-04-02
US20130011869A1 (en) 2013-01-10
ES2655099T3 (es) 2018-02-16
BR112012025082A8 (pt) 2017-10-10
CN102822338A (zh) 2012-12-12
JP5860394B2 (ja) 2016-02-16
HK1248249A1 (zh) 2018-10-12

Similar Documents

Publication Publication Date Title
LTPA2019011I1 (lt) CGRP antikūnai
BR112012025082A2 (pt) novos anticorpos monoclonais e método de análise imunológica de dímero-d
HK1256304A1 (zh) 用於生成單克隆抗體的方法和試劑
BRPI0822447A2 (pt) Anticorpo monoclonal e método do mesmo
SMT201700083B (it) Anticorpi monoclonali
SMT201400184B (it) Anticorpi monoclonali che legano b7h6 e loro usi
CY2017025I2 (el) Αντιδοτα αντιπηκτικων
HK1219965A1 (zh) 對磷脂醯肌醇蛋白聚糖 特異的人單克隆抗體及其用途
DK2521736T3 (da) Humaniserede antistoffer
DK2785375T3 (da) Anti-pd-l1-antistoffer og anvendelser deraf
DK2569013T3 (da) Humaniserede og kimære monoklonale antistoffer til cd47
BR112012025695A2 (pt) método de seleção de célula b e método de produção de um anticorpo
DK2825559T3 (da) Letisolerbare bispecifikke antistoffer med nativt immunoglobulinformat
BR112012030311A2 (pt) anticorpo
BR112013032552A2 (pt) variantes de anticorpos monoclonais humanizados imunomoduladores
BR112013022797A2 (pt) anticorpos anti-ctla4 humanizados
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
EP2525813A4 (en) ANTIBODIES TO ILT5 AND ILT5 BINDING ANTIBODY FRAGMENTS
EP2525822A4 (en) IMMUNOREGULATION WITH ANTI-ILT5 ANTIBODIES AND ILT5-BINDING ANTIBODY FRAGMENTS
CR20170001A (es) Anticuerpos anti factor d humanizados
BR112013002297A2 (pt) anticorpos humanizados seguros e funcionais
BRPI0916915A2 (pt) anticorpos anti-il-17a/f de reatividade cruzada e biespecíficos
DK3351255T3 (da) Modificerede anti-cd4-antistoffer
DK2531526T3 (da) Fremgangsmåde til opnåelse af antistoffer
CO6791565A2 (es) Anticuerpos anti-notch1

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: LSI MEDIENCE CORPORATION (JP)

B25G Requested change of headquarter approved

Owner name: LSI MEDIENCE CORPORATION (JP)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL